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Abstract The X gene product of the human hepatitis B virus
(HBx), a major factor responsible for hepatitis and hepato-
cellular carcinoma, modulates transactivation by a variety of
transcription factors. Herein, expression of the phosphoenolpyr-
uvate carboxykinase (PEPCK) gene was found to be regulated
transcriptionally by HBx through two distinct promoter regions.
The cAMP response element (CRE)-1 site within the proximal
promoter region mediated the HBx-induced transactivation of
the PEPCK gene through C/EBPK and ATF-2. A retinoid X
receptor (RXR) response element within the distal promoter
region also contributed to the HBx-induced transactivation.
Consistent with these results, HBx directly interacted with RXR,
and the interaction interfaces were localized to the transactiva-
tion domain of HBx and the ligand binding domain of
RXR. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Hepatitis B virus (HBV) mainly infects liver tissue and is
associated with hepatitis and hepatocellular carcinomas [1,2].
Several signi¢cant ¢ndings suggest that HBV-X protein (HBx)
could be a causative factor in the progression of these diseases
[3]. HBx is known to transcriptionally regulate a variety of
cellular and viral genes. The ¢nding that HBx itself does not
bind to double-stranded DNA and that genes stimulated by
HBx lack any obvious consensus sequences suggest that HBx
stimulates transcription presumably by interacting with cellu-
lar proteins and/or components of signal transduction path-
ways. Consistent with this hypothesis, HBx has been shown to
directly interact with transcriptional factors such as RPB5 of
RNA polymerase [4], TATA binding protein [5] and bZIP
proteins [6], and to activate signal transduction pathways,
including Ras/Raf/MAP kinase, protein kinase C, Jak1-
STAT and NF-UB [7,8].
The phosphoenolpyruvate carboxykinase (PEPCK) pro-
moter is a well-de¢ned model for metabolic regulation of
gene expression [9]. PEPCK, which catalyzes a regulatory
step in gluconeogenesis, is expressed primarily in the liver,
kidney, small intestine and adipose tissue, where its synthesis
is regulated at the level of transcriptional initiation. The
PEPCK promoter integrates cues arising from diverse signal-
ing pathways. PEPCK mRNA is induced by glucocorticoids,
thyroid hormone or glucagon [10], whereas insulin results in a
repression of the promoter activities in a dominant manner
[11]. The PEPCK promoter fragment encompassing 3460 to
+73 was demonstrated to be su⁄cient for hormonal regula-
tion in liver, and many of the transcription factors that bind
elements in this region have been identi¢ed [12,13]. Proteins
demonstrated to bind and impact regulation of the PEPCK
promoter include CREB, C/EBPK, C/EBPL, ATF-2, NF1,
HNF3, glucocorticoid receptor (GR), thyroid hormone recep-
tor (TR), retinoic acid receptor (RAR) and retinoid X recep-
tor (RXR). The energy balance state can e¡ect signals for the
PEPCK gene regulation through activating CREB, C/EBPK
and C/EBPL [14], whereas ATF-2 mediates the stress response
signals [15].
The overlapping expression pro¢le of HBV and PEPCK led
us to determine whether HBV infection impacts transcription
of the PEPCK gene. Notably, adenovirus infection was pre-
viously shown to regulate the PEPCK gene transcription
through E1A expression [16]. In this report, we show that
HBx indeed regulates the transcription of the PEPCK gene
through direct interaction with both RXR and CRE-1 binding
proteins.
2. Materials and methods
2.1. Plasmids
pSG5-HBx, -D1 and -D5 constructs for mammalian transient trans-
fection were kindly provided by Dr. Seishi Murakami (Kanazawa
University, Japan) [17]. HBx, D1 and D5 fragments ampli¢ed by
polymerase chain reaction (PCR) were cloned into the BamHI and
EcoRI restriction sites of pCMV-GAL4 plasmid (pCMX1) for the
mammalian two-hybrid assays. The reporter plasmids, PEPCK-275
and PEPCK-543, were constructed by using PCR ampli¢ed fragments
of rat genomic DNA, which encompasses positions 3275/3543
through +73 of the PEPCK promoter [18].
2.2. Cell culture and transient transfection
HepG2 cells and HeLa cells were maintained in Dulbecco’s modi-
¢ed Eagle’s medium supplemented with 10% heat-inactivated fetal
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bovine serum (FBS) (Gibco BRL) and 1% antibiotics. The cells were
seeded in 24-well plates with growth medium supplemented with 10%
charcoal-stripped serum and co-transfected with pRSV/L-gal vector
and expression vectors for HBx, D1, D5, C/EBPK, ATF-2 and
RXR. Total amounts of expression vectors were kept constant by
adding pcDNA3.1/His C, along with the reporter constructs contain-
ing the PEPCK gene promoter sequences. The relative luciferase and
L-galactosidase activities were determined as described [19]. All the
transfection results represent the mean of three independent experi-
ments.
2.3. Gel shift analysis
Full-length C/EBPK and ATF-2 proteins were prepared by in vitro
transcription-coupled translation (TNT, Promega, Madison, WI,
USA) under conditions described by the manufacturer. A set of dou-
ble-stranded oligonucleotides encoding the PEPCK CRE-1 sequence
(promoter positions 99 to 76) was used as a probe: 5P CCGGC-
CCCTTACGTCAGAGGCG. Binding reactions were assembled with-
out the labeled probe and held 5 min on ice followed by 5 min at
room temperature. The labeled probe was added and further incu-
bated for 30 min. Samples were separated in 4% acrylamide^0.5U
TBE (0.045 M Tris, 0.045 M boric acid, 1.0 mM EDTA, pH 8.0)
gels run at constant voltage (200 V).
2.4. Glutathione S-transferase (GST)-pull down assay
GST-fusion proteins were puri¢ed as described previously [19].
Equal amounts (approximately 1 Wg) of GST, GST-HBx, GST-D1
or GST-D5 immobilized on 20 Wl of glutathione Sepharose beads
were incubated with in vitro translated 35S-RXR, RXR-ABC, RXR-
ligand binding domain (LBD), and RAR in the reaction bu¡er (25
mM HEPES, pH 7.6, 20% glycerol, 120 mM NaCl, 0.2 mM EDTA,
1 mM DTT, 0.1% bovine serum albumin, 0.1% Triton X-100) in the
absence or presence of 100 nM of 9-cis-RA for 4 h at 4‡C. After
washing three times with phosphate bu¡ered saline, the bound pro-
teins were eluted with reduced glutathione and boiled with an equal
volume of 2U Laemmli sample bu¡er at 100‡C for 3 min prior to
electrophoresis. After electrophoresis, the gel was dried and analyzed
with the Molecular Imager Fx (Bio-Rad).
2.5. Mammalian two-hybrid assay
Cells were seeded with growth medium supplemented with 10%
FBS and 1% antibiotics, and co-transfected with expression vectors
encoding Gal4-DNA binding domain fusions (pCMX/Gal4N-D1 or
pCMX/Gal4N-D5) and VP16-activation domain fusions (pCMX/
VP16/-, pCMX/VP16-RXR-LBD or pCMX/VP16-RAR-LBD) as
well as the previously described Gal4-tk-luc reporter plasmid. After
48 h, cells were harvested and the luciferase activity was normalized to
the L-galactosidase expression. All the results represent the average of
at least three independent experiments.
3. Results
3.1. HBx stimulates transcription of the PEPCK promoter
To examine the e¡ect of HBV on the regulation of PEPCK
promoter activity, we transfected an expression vector encod-
ing HBx, a transactivator protein of HBV, into HepG2 cells.
For these experiments, we used two di¡erent PEPCK pro-
moter/reporter plasmids, PEPCK-275 and PEPCK-543 (Fig.
1A). Transfection with HBx expression plasmid resulted in
increased luciferase activity of both PEPCK reporters (Fig.
1B). HBx stimulated the promoter activity of PEPCK-275
construct approximately four-fold. The HBx-D1 fragment
containing the HBx transactivation domain resulted in ap-
proximately six-fold activation, whereas the N-terminal do-
main D5 led to marginal transactivation (Fig. 1B). Thus,
HBx appeared to positively regulate the PEPCK promoter
activity in a manner speci¢cally dependent on the transactiva-
tion domain of HBx. Interestingly, the transcriptional activity
of the PEPCK-543 reporter was more strongly induced by
HBx than that of the PEPCK-275 reporter. For instance,
coexpression of D1 resulted in approximately nine-fold poten-
tiation (Fig. 1B). Thus, not only the region B but also the
region A of the PEPCK promoter (Fig. 1A) should contain
HBx-responsive elements that mediate the HBx-dependent
transactivation of the PEPCK promoter constructs.
3.2. C/EBPK and ATF-2 mediate the HBx-dependent
transactivation of PEPCK promoter through the PEPCK
CRE-1 site
We next wanted to determine the role of the CRE-1 site
within the PEPCK-275 construct in the HBx-mediated trans-
activation. Previous reports have shown that both CREB/
ATF and C/EBP proteins bind this site [15]. Thus, we exam-
ined whether overexpression of C/EBPK or ATF-2 can en-
hance the HBx-induced transactivation activity of the PEPCK
promoter. Cotransfection of HBx with C/EBPK exerted a syn-
ergistic e¡ect on the transcription activities of the PEPCK-275
construct (Fig. 2A). Similar results were also obtained with
ATF-2. Given the presence of the additional CRE sites in the
PEPCK-543 construct, one might expect stronger transactiva-
tion of the PEPCK-543 construct relative to the PEPCK-275.
However, overexpression of C/EBPK or ATF-2 did not in-
crease the transcription activity of the PEPCK-543 construct
beyond that of the PEPCK-275 reporter (Fig. 2A). These
results suggest that C/EBPK or ATF-2 mediates the HBx-in-
duced transactivation of the PEPCK-275 promoter construct,
Fig. 1. HBx enhances the PEPCK transactivation. A: Schematic
representation of two luciferase reporter constructs as well as vari-
ous HBx constructs are shown. The region A contains the glucocor-
ticoid response unit (GRU) composed of two glucocorticoid regula-
tory elements, three accessory factor binding sites and a CRE. This
region provides several factor binding sites for RAR, RXR, GR,
TR, C/EBP, and HNF-3 [22]. The region B contains CRE-1 (391
to 384) and is immediately adjacent to a nuclear factor 1 (NF1)
binding site [22]. The HBx fragments containing two di¡erent func-
tional domains, the regulatory domain (D5) and the transactivation
domain (D1), are as shown [17]. B: The hepatoma cell line HepG2
was transfected with 20 ng of reporter plasmid alone, or along with
50 ng of the indicated mammalian expression vector. All the trans-
fection results were normalized to L-galactosidase activity, and the
presented results represent the average of three independent experi-
ments, with fold induction over the level observed with the reporter
alone.
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whereas yet other factors are involved in the HBx-mediated
transactivation through the region A of the PEPCK promoter
(i.e. the PEPCK promoter sequences 3543 to 3276). Since
HBx stimulates in vitro DNA binding of a variety of cellular
proteins that contain bZIP DNA binding domains [6], we
examined whether HBx increases the DNA binding activity
of those factors at the PEPCK CRE-1 site. Interestingly,
HBx signi¢cantly enhanced the DNA binding activity of C/
EBPK and ATF-2 in a dose-dependent manner (Fig. 2B).
Thus, the observed HBx-dependent transactivation of the
PEPCK promoter constructs may involve the HBx-dependent
increase in the DNA binding activity of C/EBPK and ATF-2,
although HBx may also a¡ect other aspects of C/EBPK and
ATF-2.
3.3. 9-cis-RA potentiates the HBx-mediated transactivation of
the PEPCK promoter
From the results presented in Fig. 1, an additional ele-
ment(s) in the promoter region A (Fig. 1A) may mediate
the HBx-dependent transactivation of the PEPCK promoter.
This region of the promoter has binding sites for nuclear
receptors [20], including RAR, RXR, GR and TR. Since
TR and RAR mediate the basal repression and GR is cyto-
plasmic in the absence of their cognate ligand, we reasoned
that RXR is a good candidate factor responsible for the HBx-
mediated transactivation of the PEPCK promoter region A.
Con¢rming this prediction, coexpression of RXR alone en-
hanced the HBx-mediated transactivation of the PEPCK-543
promoter, which was further stimulated by 9-cis-RA (Fig.
3A). This increased transcriptional activity by RXR and
HBx was not observed with the PEPCK-275 promoter (results
not shown). Interestingly, coexpression of the HBx-D1 frag-
ment alone stimulated the PEPCK^RXR transactivation at a
level similar to that observed with the full length HBx. In
contrast, RAR did not enhance the HBx-induced transactiva-
tion of the PEPCK-543 construct (results not shown). These
results indicate that RXR, either in the absence or presence of
9-cis-RA, renders HBx to stimulate the PEPCK transactiva-
tion through the PEPCK promoter region A. Consistent with
these results, 9-cis-RA increased the HBx-dependent transac-
tivation of the PEPCK-543 reporter construct, whereas all-
trans-RA, dexamethasone and T3 were without any signi¢cant
e¡ect, although treatment of each ligand marginally increased
the PEPCK-543 transactivation in the absence of HBx (ap-
proximately two-fold) (Fig. 3B).
3.4. HBx can directly interact with RXR
Given the combined results of HBx and RXR (Fig. 3), we
Fig. 2. C/EBPK and ATF-2 mediate the HBx-induced transactivation of the PEPCK gene expression. A: Expression vectors for C/EBPK and
ATF-2 were transfected into HepG2 cells along with reporter constructs PEPCK-275 or PEPCK-543, either in the presence or absence of HBx-
expression plasmid. All the transfection results were normalized to L-galactosidase activity, and the presented results represent the average of
three independent experiments, with fold induction over the level observed with the reporter alone. B: A double-stranded oligonucleotide probe
containing the CRE-1 site of the PEPCK promoter was used in electrophoretic mobility shift analysis. 2 Wl of in vitro transcription coupled
translation reactions was added in a binding reaction either in the absence or presence of increasing amount of GST protein or GST-HBx pro-
tein.
Fig. 3. HBx and RXR synergize in the PEPCK transactivation. HepG2 cells were transfected with the indicated expression plasmids and as-
sayed for reporter activity with the PEPCK-543 reporter construct. 20 ng of reporter vector was transfected into HepG2 cells along with 50 ng
of the indicated expression plasmid, either in the absence or presence of 100 nM of 9-cis-RA (A, B), all-trans-RA, dexamethasone or triiodo-
thyronine (B). 48 h after transfection, cells were harvested for luciferase activities. All the transfection results were normalized to L-galactosi-
dase activity, and the presented results represented the average of four independent experiments, with fold induction over the level observed
with the reporter alone.
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tested whether HBx protein directly interacts with RXR. GST
fusion proteins encoding the full-length HBx as well as D1
and D5 were produced in bacteria, immobilized on gluta-
thione Sepharose beads, and incubated with in vitro-trans-
lated 35S-labeled RXR, RXR-ABC, RXR-LBD and RAR.
Consistent with the transfection results, the full-length HBx
protein and D1 interacted with RXR in a 9-cis-RA-enhanced
manner (Fig. 4A). However, D5 encoding the regulatory do-
main of HBx failed to associate with RXR. In addition, this
interaction was mapped to the LBD of RXR. RAR as well as
the ABC domains of RXR did not interact with HBx. From
these results, the transactivation domain of HBx was sug-
gested to speci¢cally associate with the LBD of RXR in a
9-cis-RA-enhanced manner. To con¢rm the association of
HBx with RXR in vivo, we utilized the mammalian two-hy-
brid assays. Coexpression of Gal4-D1 and VP16-RXR-LBD
enhanced the Gal4-tk-luc-dependent transactivation in a li-
gand-dependent manner, whereas Gal4-D5 was inert. These
results indicate that the transactivation domain of HBx inter-
acts with RXR in vivo in a ligand-dependent manner. As
suspected, HBx did not interact with RAR in the mammalian
two-hybrid assay (results not shown).
4. Discussion
In conclusion, we have shown that the PEPCK promoter
activity is up-regulated by HBx, which involved the functional
interactions of HBx with both bZIP proteins and RXR. HBx
is an important regulator of HBV genome expression, infec-
tiousness and proliferation of liver cells. Chronic liver infec-
tion by HBV leads to profound changes in hepatocyte phys-
iology including the expression of various proteins that are
not normally expressed or under-expressed in uninfected he-
patocytes, including genes involved with gluconeogenesis.
Thus, this report adds the PEPCK promoter to the list of
gluconeogenesis genes up-regulated by HBx.
Finally, it is interesting to note that the PEPCK promoter is
a typical enhancersome, comprised of a series of cis-elements,
including binding sites for bZIP proteins and nuclear recep-
tors. Our ¢ndings that HBx functionally interact with RXR
and bZIP proteins may shed some light into how the PEPCK
enhancersome is regulated upon HBV infection. HBx can sta-
bilize the assembly of PEPCK enhancersome through associ-
ation with bZIP proteins and RXR. In addition, HBx may
enhance the function of PEPCK enhancersome by juxtaposing
components of the transcriptional machinery in a more favor-
able orientation [21], and may also play a role in recruiting
transcriptional coactivators.
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